() d41d8cd98f00b204e9800998ecf8427e declared having carried out a Purchase / Acquisition involving 63 Action at a unit price of 0 € for a total amount of 0€. Shares were issued to satisfy the share awards granted in 2018 under the Company's Performance Share Plan (the “Awards”). The Awards vested on 17 December 2021 and must be settled by 15 March 2022 pursuant to the terms of the Awards and the Company’s Performance Share Plan.">

TransactionACACIA PHARMA GROUP by Bolinder Michael

Bolinder Michael

Résumé

As of 2022-03-15 in his capacity as () d41d8cd98f00b204e9800998ecf8427e declared having carried out a Purchase / Acquisition involving 63 Action at a unit price of 0 € for a total amount of 0€. Shares were issued to satisfy the share awards granted in 2018 under the Company's Performance Share Plan (the “Awards”). The Awards vested on 17 December 2021 and must be settled by 15 March 2022 pursuant to the terms of the Awards and the Company’s Performance Share Plan.

Issuer

ACACIA PHARMA GROUP

ISIN code: GB00BYWF9Y76
Quantité

63

Euronext Brussels
Montant

0€

0€ / Action